Express News | Ardelyx Appoints Merdad Parsey, M.d., Ph.d. to Its Board of Directors
Press Release: Ardelyx Appoints Merdad Parsey, M.D., Ph.D. to Its Board of Directors
Earnings Preview: Ardelyx to Report Financial Results Post-market on May 01
Ardelyx Announces Three Abstracts Accepted for Poster Presentations at Digestive Disease Week 2025 Conference
Ardelyx to Report First Quarter 2025 Financial Results on May 1, 2025
Is Ardelyx Inc. (NASDAQ:ARDX) the Best Biotech Penny Stock to Buy According to Hedge Funds?
Ardelyx, Inc. (NASDAQ:ARDX): When Will It Breakeven?
$ARDX Stock Is up 3% Today. Here's What We See in Our Data.
Ardelyx to Share a Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH (Tenapanor) at the National Kidney Foundation Spring Clinical Meetings
Ardelyx, Inc.'s (NASDAQ:ARDX) Recent 6.4% Pullback Adds to One-year Year Losses, Institutional Owners May Take Drastic Measures
World IBS Day - April 19th: Educating Others About Irritable Bowel Syndrome
Ardelyx Announces the First Recipients of Derek Forfang Patient Advocate Award
Piper Sandler Initiates Ardelyx(ARDX.US) With Hold Rating, Announces Target Price $8
Piper Sandler Sticks to Their Hold Rating for Ardelyx (ARDX)
Possible Bearish Signals With Ardelyx Insiders Disposing Stock
Vistra, Ardelyx, Zscaler, Lexicon, Arista: Trending by Analysts
Insider Sale: President & CEO of $ARDX Sells 41,668 Shares
Ardelyx Price Target Announced at $15.00/Share by Scotiabank
Ardelyx Initiated at Sector Outperform by Scotiabank
Ladenburg Thalmann Initiates Ardelyx(ARDX.US) With Buy Rating, Announces Target Price $11